The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday.

In his new action movie ‘Flight Risk’, Mark Wahlberg plays a villain – and you can tell because his character is balding.

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

Johnson & Johnson has received FDA approval for Spravato nasal spray as the first and only monotherapy for adults with treatment-resistant depression.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

Find Stroke In Winters Latest News, Videos & Pictures on Stroke In Winters and see latest updates, news, information from NDTV.COM. Explore more on Stroke In Winters.

Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...